ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Roivant, Mateon to develop Covid-19 drug candidates pharmaceutical-technology
March 20, 2020Roivant Sciences is in discussion with the US, Europe and Asian regulators to develop gimsilumab for treating acute respiratory distress syndrome (ARDS) caused by Covid-19.
Pharma Sources Insight July 2025
